NCT01536639 - Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

454

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

Administered by subcutaneous injection. The physician determined the starting dose and frequency, as well as later changes to either dose or frequency, if any

Trial Locations (1)

811 05

Novo Nordisk Investigational Site, Bratislava